All > Massachusetts Investigators

David C. Christiani, MD

Harvard School of Public Health

Boston, Massachusetts - 02115

CLINICAL TRIALS 2
CONDITIONS3
INTERVENTIONS5
SINCE

Genetic and Environmental Risk Factors Related to Esophageal Cancer

DNA Analysis of Blood and Tissue From Patients With Lung Cancer

September 2005 - June 2011

Lung Neoplasms

Esophageal Diseases

Esophageal Neoplasms

Laboratory Biomarker Analysis

Questionnaire Administration

Polymorphism Analysis

Polymerase Chain Reaction

Dna Analysis

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

David C. Christiani, MD

Harvard School of Public Health

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP